Back

Quantification of cardiac creatine and triglycerides in amyloidosis using proton MR spectroscopy

26 August 2018 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: Emerging CMR technologies Technology and Physics ESC Premium Access ESC Congress 2018

About the speaker

Photo
Miss Sophie Peereboom

Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
CMR and the clinical impact of advanced technology - State of the Art
Doctor R. Kwong (Boston, US)
Slides Video
Presentation thumbnail
Accuracy of non contrast magnetic resonance for clinical diagnosis of cardiac amyloidosis - a 868 patient prospective study
Doctor M. Boldrini (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
The future of CMR for tissue characterization: More teslas or more trials?
Professor E. Nagel (Frankfurt, DE)
Slides Video

Access the full session

Session thumbnail
Emerging CMR technologies

The Event

Event poster

ESC Congress 2018

26 August 2018 09:06 CET
You may be interested in
thumbnail
Congress Presentation
Investigating myocardial energetic deficit across the spectrum of cardiac disease
26 August 2022
thumbnail
Congress Session
Cardiac amyloidosis and heart failure
20 May 2025
thumbnail
Congress Presentation
Cardiac MRI as a possible alternative to echocardiography for therapeutic response monitoring in ATTR cardiomyopathy: a multiparametric evaluation in patisiran treated patients
11 May 2023
thumbnail
Congress Presentation
Prognostication of cardiac amyloidosis by pittsburgh b compound positron emission tomography
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources